The Big Ten cancer centers have united…

to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities.

“The premise of the Big Ten Cancer Research Consortium is to provide a unified network of high-level academic institutions working together for the conduct of novel science-driven clinical trials which incorporate major bench-to-bedside and back translational components arising from the labs and departments at our various centers.  In addition, it is envisioned that such a consortium will provide a much needed solution to the gap in the national trials networks for junior investigators to lead such trials under supervision and mentorship from well seasoned senior investigators.”  –Noah Hahn, MD